Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mehow InnovativeSZSE:301363 -4.95%93 Net Margin % is 14.06% as of Mar. 2026, which is 45% below its 10-year median of 25.34. GuruFocus rates SZSE:301363 with a GF Score™ of 93/100 and a GF Value™ of ¥21.04 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Mehow Innovative ranks better than 84.93% on this metric.
The historical rank and industry rank for Mehow Innovative's Net Margin % or its related term are showing as below:
SZSE:301363'
s Net Margin % Range Over the Past 10 Years
Min: 16.61 Med: 25.34 Max: 31.31
Current: 16.61
SZSE:301363's Net Margin % is ranked better than 84.93% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.11
vs SZSE:301363: 16.61
Mehow Innovative (SZSE:301363) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Mehow Innovative Net Margin % Related Terms
Mehow Innovative Net Margin % Historical Data
* Premium members only.
The historical data trend for Mehow Innovative's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:301363 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Mehow Innovative's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mehow Innovative Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mehow Innovative's Net Margin % distribution charts can be found below:
* The bar in red indicates where Mehow Innovative's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mehow Innovative (SZSE:301363) has a Net Margin % of 14.06% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Mehow Innovative and its competitors. This is 45% below median its historical median of 25.34. Over the past decade, Mehow Innovative's Net Margin % has ranged from 16.61 to 31.31. According to the industry distribution chart, Mehow Innovative ranks #123 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 15.1%.
Is Mehow Innovative's Net Margin % too high?
Mehow Innovative's current Net Margin % of 14.06% is 45% below median its 10-year median of 25.34. Over the past 10 years, this metric has ranged from a low of 16.61 to a high of 31.31. The Medical Devices & Instruments industry median Net Margin % is 2.11. Mehow Innovative's value of 14.06% is 566.4% above this industry median. Based on the distribution chart, Mehow Innovative ranks #123 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Mehow Innovative has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mehow Innovative's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Mehow Innovative ranks #123 out of 816 companies for Net Margin %. This places Mehow Innovative in the top 15% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.11. Mehow Innovative's value of 14.06% is 566.4% above this benchmark. Historically, Mehow Innovative's own Net Margin % has ranged from 16.61 to 31.31 over the past decade. While the company's 10-year median is 25.34 vs. the industry median of 2.11, Mehow Innovative has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.11, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mehow Innovative's current Net Margin % of 14.06% is 566.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Mehow Innovative and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mehow Innovative's current Net Margin % is 14.06%, which is 45% below median its own 10-year median of 25.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mehow Innovative stock overvalued right now?
Based on GuruFocus' analysis, Mehow Innovative (SZSE:301363) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.04, compared to a current price of ¥16.14 — trading 23.3% below its estimated fair value. The current Net Margin % is 14.06%, which is 45% below median its 10-year median of 25.34 and 566.4% above the Medical Devices & Instruments industry median of 2.11. Mehow Innovative's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Mehow Innovative (SZSE:301363), the current Net Margin % is 14.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mehow Innovative (SZSE:301363) Overvalued in 2026?
Based on GuruFocus' analysis, Mehow Innovative stock appears to be undervalued.
The current stock price of ¥16.14 is trading 23.3% below its estimated GF Value™ of ¥21.04.
GuruFocus considers Mehow Innovative to be Modestly Undervalued.
Key valuation signals for SZSE:301363:
Net Margin %: 14.06% (45% below median its 10-year median of 25.34)
GF Value™: ¥21.04 vs. price of ¥16.14 (23.3% below fair value)
Industry Position: 566.4% above the Medical Devices & Instruments median (#123 of 816)
No single metric tells the full story. See the SZSE:301363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301363 has been successfully added to your 
